June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
Missing the boat when buying a chiropractic table?- How payroll fraud schemes work and what to look for
- PFCS announces role with NFL teams
- 4 tips help you get paid for your work
- Emerson Ecologics selected as exclusive distributor for Klean Athlete
- Treating chronic chest pain with chiropractic instruments
